Velzatinib

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Gastrointestinal NeoplasmsGastrointestinal Stromal Neoplasms

Phase 2

A Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib

RecruitingNCT07689201

GlaxoSmithKlineGastrointestinal Neoplasms

Start: 2026-08-17End: 2029-08-17Target: 24Updated: 2026-09-09

Phase 3

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

RecruitingNCT07585266

GlaxoSmithKlineGastrointestinal Stromal Neoplasms

Start: 2026-07-27End: 2032-09-28Target: 800Updated: 2026-08-19